A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
According to MarketsandMarkets, The report Next-generation Sequencing Services Market is projected to grow from USD 3.80 billion in 2025 and ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
THETFORD MINES, QC, Dec. 22, 2025 /CNW/ – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative ...
The ongoing Italian clinical and research FPG500 program is designed to tailor matched targeted therapies (MTTs) based on "biomarkers predictive of response identified by comprehensive genome profiling ...
GUANGZHOU, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing evidence on the utility of ctDNA testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback